S. 735 updates and expands a federal program focused on sickle cell disease and other blood disorders by increasing funding and broadening the scope of supported activities. The bill more than doubles annual funding from $4.46 million to $8.21 million for fiscal years 2025 through 2029, allowing the government to provide grants and enter into cooperative agreements (in addition to contracts) with organizations working on these issues. The legislation refocuses the program's mission to emphasize treating sickle cell disease and preventing and treating its complications, rather than just prevention and treatment generally. This bill affects patients with sickle cell disease and other hereditary blood disorders, as well as medical researchers, treatment providers, and public health organizations involved in addressing these conditions. The bill also expresses Congress's intent to encourage further research into the causes of and potential cures for heritable blood disorders.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.